Home›Stock Screener›Bilcare›Quarterly Results

Bilcare Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹-23 Cr
QSept 2025
Quarterly Results

In Sept 2025, Bilcare (BI) reported revenue ₹183 Cr and net profit ₹-23 Cr — revenue -11.2% YoY. Also explore BI share price history to track price trends across different timeframes.

BI Quarterly Results — Revenue, Profit & EPS Highlights

Bilcare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Bilcare stock price NSE.

  • Revenue of ₹183 Cr in Sept 2025 (-14.9% vs Mar 2025, -11.2% vs Sept 2024)
  • Net Profit of ₹-23 Cr in Sept 2025 (-560.0% vs Mar 2025, +23.3% vs Sept 2024)
  • EBITDA of ₹8 Cr in Sept 2025 (-72.4% vs Mar 2025)
  • Operating Margin of 2.0% in Sept 2025 (-2.0pp vs Mar 2025)
  • Earnings Per Share of ₹-5.25 in Sept 2025 (-217.2% vs Mar 2025)

Bilcare Quarterly Results — Revenue, EBITDA, Net Profit & EPS

BI quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 183 215 192 187 206 -14.9% -11.2%
Net Profit (₹ Cr) -23 5 -10 -13 -30 - -
EBITDA (₹ Cr) 8 29 17 16 2 - -
EPS (₹) -5.25 4.48 -1.61 -2.53 -6.81 - -
Operating Margin (%) 2.0% 4.0% 6.0% 6.0% -1.0% - -

BI Share Price Trend — 1-Year Movement Across Quarterly Results

Bilcare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with BI fair value to assess whether the stock is under or overvalued.

Profitability Ratios

Profit Margin -12.6%
EBITDA Margin 4.4%
Operating Margin 2.0%
ROE (Annual) -15.6%

Balance Sheet Highlights

Total Assets ₹1,417 Cr
Total Equity ₹590 Cr
Current Assets ₹343 Cr
Current Liabilities ₹488 Cr

Cash Flow Analysis

Operating Cash Flow ₹63 Cr
Investing Cash Flow ₹-106 Cr
Financing Cash Flow ₹36 Cr
Net Cash Flow ₹-8 Cr

Current Market Data

Current Price ₹64.52
Exchange NSE
Last Updated May 15, 2026

Revenue Trend (₹ Cr)

Dec 2025 187
Jun 2025 192
Mar 2025 215
Sept 2025 183

Net Profit Trend (₹ Cr)

Dec 2025 -13
Jun 2025 -10
Mar 2025 5
Sept 2025 -23

Operating Margin Trend (%)

Dec 2025 6.0%
Jun 2025 6.0%
Mar 2025 4.0%
Sept 2025 2.0%

BI vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Bilcare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹450,643.09 Cr 1878.2 14,875 3,125 +10.8% - 21.0% 144.5
Divis Laboratories
Sept 2025 		₹179,470.03 Cr 6760.5 2,860 689 +7.1% - 24.1% 260.3
Torrent Pharmaceuti…
Sept 2025 		₹149,048.00 Cr 4405.7 3,219 591 +11.3% - 18.4% 251.2
Cipla
Mar 2026 		₹116,053.85 Cr 1432.1 6,612 543 -14.3% -4.0% 8.2% 208.5
Dr Reddys Laborator…
Mar 2026 		₹108,804.06 Cr 1336.7 7,996 221 -12.5% -11.5% 2.8% 504.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores